Deleting Full Length Titin Versus the Titin M-Band Region Leads to Differential Mechanosignaling and Cardiac Phenotypes.


Journal

Circulation
ISSN: 1524-4539
Titre abrégé: Circulation
Pays: United States
ID NLM: 0147763

Informations de publication

Date de publication:
09 04 2019
Historique:
pubmed: 1 2 2019
medline: 30 1 2020
entrez: 1 2 2019
Statut: ppublish

Résumé

Titin is a giant elastic protein that spans the half-sarcomere from Z-disk to M-band. It acts as a molecular spring and mechanosensor and has been linked to striated muscle disease. The pathways that govern titin-dependent cardiac growth and contribute to disease are diverse and difficult to dissect. To study titin deficiency versus dysfunction, the authors generated and compared striated muscle specific knockouts (KOs) with progressive postnatal loss of the complete titin protein by removing exon 2 (E2-KO) or an M-band truncation that eliminates proper sarcomeric integration, but retains all other functional domains (M-band exon 1/2 [M1/2]-KO). The authors evaluated cardiac function, cardiomyocyte mechanics, and the molecular basis of the phenotype. Skeletal muscle atrophy with reduced strength, severe sarcomere disassembly, and lethality from 2 weeks of age were shared between the models. Cardiac phenotypes differed considerably: loss of titin leads to dilated cardiomyopathy with combined systolic and diastolic dysfunction-the absence of M-band titin to cardiac atrophy and preserved function. The elastic properties of M1/2-KO cardiomyocytes are maintained, while passive stiffness is reduced in the E2-KO. In both KOs, we find an increased stress response and increased expression of proteins linked to titin-based mechanotransduction (CryAB, ANKRD1, muscle LIM protein, FHLs, p42, Camk2d, p62, and Nbr1). Among them, FHL2 and the M-band signaling proteins p62 and Nbr1 are exclusively upregulated in the E2-KO, suggesting a role in the differential pathology of titin truncation versus deficiency of the full-length protein. The differential stress response is consistent with truncated titin contributing to the mechanical properties in M1/2-KOs, while low titin levels in E2-KOs lead to reduced titin-based stiffness and increased strain on the remaining titin molecules. Progressive depletion of titin leads to sarcomere disassembly and atrophy in striated muscle. In the complete knockout, remaining titin molecules experience increased strain, resulting in mechanically induced trophic signaling and eventually dilated cardiomyopathy. The truncated titin in M1/2-KO helps maintain the passive properties and thus reduces mechanically induced signaling. Together, these findings contribute to the molecular understanding of why titin mutations differentially affect cardiac growth and have implications for genotype-phenotype relations that support a personalized medicine approach to the diverse titinopathies.

Sections du résumé

BACKGROUND
Titin is a giant elastic protein that spans the half-sarcomere from Z-disk to M-band. It acts as a molecular spring and mechanosensor and has been linked to striated muscle disease. The pathways that govern titin-dependent cardiac growth and contribute to disease are diverse and difficult to dissect.
METHODS
To study titin deficiency versus dysfunction, the authors generated and compared striated muscle specific knockouts (KOs) with progressive postnatal loss of the complete titin protein by removing exon 2 (E2-KO) or an M-band truncation that eliminates proper sarcomeric integration, but retains all other functional domains (M-band exon 1/2 [M1/2]-KO). The authors evaluated cardiac function, cardiomyocyte mechanics, and the molecular basis of the phenotype.
RESULTS
Skeletal muscle atrophy with reduced strength, severe sarcomere disassembly, and lethality from 2 weeks of age were shared between the models. Cardiac phenotypes differed considerably: loss of titin leads to dilated cardiomyopathy with combined systolic and diastolic dysfunction-the absence of M-band titin to cardiac atrophy and preserved function. The elastic properties of M1/2-KO cardiomyocytes are maintained, while passive stiffness is reduced in the E2-KO. In both KOs, we find an increased stress response and increased expression of proteins linked to titin-based mechanotransduction (CryAB, ANKRD1, muscle LIM protein, FHLs, p42, Camk2d, p62, and Nbr1). Among them, FHL2 and the M-band signaling proteins p62 and Nbr1 are exclusively upregulated in the E2-KO, suggesting a role in the differential pathology of titin truncation versus deficiency of the full-length protein. The differential stress response is consistent with truncated titin contributing to the mechanical properties in M1/2-KOs, while low titin levels in E2-KOs lead to reduced titin-based stiffness and increased strain on the remaining titin molecules.
CONCLUSIONS
Progressive depletion of titin leads to sarcomere disassembly and atrophy in striated muscle. In the complete knockout, remaining titin molecules experience increased strain, resulting in mechanically induced trophic signaling and eventually dilated cardiomyopathy. The truncated titin in M1/2-KO helps maintain the passive properties and thus reduces mechanically induced signaling. Together, these findings contribute to the molecular understanding of why titin mutations differentially affect cardiac growth and have implications for genotype-phenotype relations that support a personalized medicine approach to the diverse titinopathies.

Identifiants

pubmed: 30700140
doi: 10.1161/CIRCULATIONAHA.118.037588
pmc: PMC6453709
mid: NIHMS1522196
doi:

Substances chimiques

Protein Kinases EC 2.7.-
titin protein, mouse EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1813-1827

Subventions

Organisme : NHLBI NIH HHS
ID : R01 HL115988
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL118524
Pays : United States
Organisme : NHLBI NIH HHS
ID : R35 HL144998
Pays : United States

Références

Mol Cell. 1998 Nov;2(5):559-69
pubmed: 9844629
Circ Res. 2013 Feb 15;112(4):664-74
pubmed: 23283722
Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H997-H1006
pubmed: 19168726
J Mol Cell Cardiol. 2013 Jan;54:90-7
pubmed: 23220127
J Muscle Res Cell Motil. 2005;26(6-8):367-74
pubmed: 16465475
Sci Transl Med. 2015 Jan 14;7(270):270ra6
pubmed: 25589632
FEBS Lett. 1998 May 22;428(1-2):111-4
pubmed: 9645487
J Cell Biol. 1989 Nov;109(5):2189-95
pubmed: 2681227
Circ Res. 2011 Jan 21;108(2):176-83
pubmed: 21127295
J Biol Chem. 2003 Feb 21;278(8):6059-65
pubmed: 12464612
J Am Heart Assoc. 2015 Nov 13;4(11):
pubmed: 26567375
Proc Natl Acad Sci U S A. 2009 Feb 17;106(7):2342-7
pubmed: 19179290
Proc Natl Acad Sci U S A. 2014 Oct 7;111(40):14589-94
pubmed: 25246556
Nat Genet. 2017 Jan;49(1):46-53
pubmed: 27869827
Science. 2005 Jun 10;308(5728):1599-603
pubmed: 15802564
Biochem Biophys Res Commun. 2007 May 25;357(1):162-7
pubmed: 17416352
Electrophoresis. 2003 Jun;24(11):1695-702
pubmed: 12783444
J Cell Biol. 2006 May 22;173(4):559-70
pubmed: 16702235
J Muscle Res Cell Motil. 2001;22(6):535-44
pubmed: 12038587
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6191-6
pubmed: 8650242
Circ Res. 2009 Sep 11;105(6):557-64
pubmed: 19679835
J Mol Med (Berl). 2016 Dec;94(12):1349-1358
pubmed: 27889803
J Cell Sci. 2002 Dec 15;115(Pt 24):4925-36
pubmed: 12432079
Circulation. 2013 Jul 2;128(1):19-28
pubmed: 23709671
FEBS J. 2009 Feb;276(3):669-84
pubmed: 19143834
Circ Res. 2009 Sep 25;105(7):631-8, 17 p following 638
pubmed: 19679839
Int J Biochem Cell Biol. 2009 Dec;41(12):2351-5
pubmed: 19666137
J Clin Invest. 2014 Mar;124(3):1364-70
pubmed: 24509080
Mol Cell Biol. 2004 Feb;24(3):1081-95
pubmed: 14729955
Circulation. 2003 Mar 18;107(10):1390-5
pubmed: 12642359
J Clin Invest. 2008 Dec;118(12):3870-80
pubmed: 19033658
Circ Res. 2007 Mar 2;100(4):456-9
pubmed: 17272810
Hum Mol Genet. 2012 Jul 15;21(14):3237-54
pubmed: 22523091
J Biol Chem. 2012 Aug 24;287(35):29273-84
pubmed: 22778266
Basic Res Cardiol. 2011 Mar;106(2):233-47
pubmed: 21069531
Science. 2001 Nov 23;294(5547):1704-8
pubmed: 11679633
EMBO J. 1997 Jan 15;16(2):211-20
pubmed: 9029142
Neuromuscul Disord. 2008 Dec;18(12):922-8
pubmed: 18948003
Science. 1995 Oct 13;270(5234):293-6
pubmed: 7569978
Proc Natl Acad Sci U S A. 2007 Feb 27;104(9):3444-9
pubmed: 17360664
Biophys J. 2015 Dec 15;109(12):2592-2601
pubmed: 26682816
Circ Res. 2003 May 2;92(8):912-9
pubmed: 12676814
Circulation. 2007 Feb 13;115(6):743-51
pubmed: 17261657
N Engl J Med. 2012 Feb 16;366(7):619-28
pubmed: 22335739
J Mol Biol. 2001 Mar 2;306(4):717-26
pubmed: 11243782

Auteurs

Michael H Radke (MH)

Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (M.H.R., C.P., C.F., M.G.).
DZHK: German Centre for Cardiovascular Research, Partner Site, Berlin, Germany (M.H.R., M.G.).

Christopher Polack (C)

Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (M.H.R., C.P., C.F., M.G.).

Mei Methawasin (M)

Department of Cellular and Molecular Medicine, University of Arizona, Tucson (M.M., H.G.). The current affiliation for P.S. and T.S. is Department of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Germany.

Claudia Fink (C)

Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (M.H.R., C.P., C.F., M.G.).

Henk L Granzier (HL)

Department of Cellular and Molecular Medicine, University of Arizona, Tucson (M.M., H.G.). The current affiliation for P.S. and T.S. is Department of Medical Microbiology and Hygiene, University Medical Center of the Johannes Gutenberg University Mainz, Germany.

Michael Gotthardt (M)

Neuromuscular and Cardiovascular Cell Biology, Max Delbrück Center for Molecular Medicine, Berlin, Germany (M.H.R., C.P., C.F., M.G.).
DZHK: German Centre for Cardiovascular Research, Partner Site, Berlin, Germany (M.H.R., M.G.).

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH